ANTH

Anthera Pharmaceuticals, Inc.
ANTH

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ANTH was delisted on the 27th of June, 2018.

Back to rankings

5 hedge funds and large institutions have $18.7K invested in Anthera Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$12.1K
2
+$425

Top Sellers

1
-$143K
2
-$132K
3
-$129K
4
VF
Virtu Financial
New York
-$50K
5
Goldman Sachs
Goldman Sachs
New York
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$17K
2
$1K
3
$714
4
–
5
–
6
–
7
–
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–